Literature DB >> 10974611

Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia.

D Gothelf1, N Soreni, R P Nachman, S Tyano, Y Hiss, O Reiner, A Weizman.   

Abstract

The hippocampus, a medial temporal lobe structure, is often considered to play an important role in the pathophysiology of schizophrenia. Recent developments of neuroimaging and molecular postmortem techniques have significantly increased our ability to study the role of discrete brain regions in the pathophysiology of schizophrenia. This article describes animal models, structural, histological, molecular biology, and neuropsychological evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia. The major findings in schizophrenic patients are decreased volumes, hypometabolism, and cytoarchitectural abnormalities which are more robust on the left hippocampus, as well as verbal memory impairment. It is yet to be determined whether these changes are neurodevelopmental or neurodegenerative in nature. Overall, these findings indicate that there are subtle changes in the hippocampus of schizophrenic patients. More comprehensive and focused hippocampal research in schizophrenia is required to elucidate the contribution of this intriguing brain structure to the pathophysiology of schizophrenia.

Entities:  

Mesh:

Year:  2000        PMID: 10974611     DOI: 10.1016/s0924-977x(00)00097-3

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  18 in total

Review 1.  Lissencephaly 1 linking to multiple diseases: mental retardation, neurodegeneration, schizophrenia, male sterility, and more.

Authors:  Orly Reiner; Sivan Sapoznik; Tamar Sapir
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 2.  Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology.

Authors:  Roger Hudson; Walter Rushlow; Steven R Laviolette
Journal:  Psychopharmacology (Berl)       Date:  2017-10-24       Impact factor: 4.530

3.  Hippocampal cannabinoid transmission modulates dopamine neuron activity: impact on rewarding memory formation and social interaction.

Authors:  Michael Loureiro; Justine Renard; Jordan Zunder; Steven R Laviolette
Journal:  Neuropsychopharmacology       Date:  2014-12-16       Impact factor: 7.853

4.  Hippocampus volume and episodic memory in schizophrenia.

Authors:  Robert J Thoma; Mollie Monnig; Faith M Hanlon; Gregory A Miller; Helen Petropoulos; Andrew R Mayer; Ron Yeo; Matt Euler; Per Lysne; Sandra N Moses; Jose M Cañive
Journal:  J Int Neuropsychol Soc       Date:  2009-02-10       Impact factor: 2.892

Review 5.  Challenges in phenotype definition in the whole-genome era: multivariate models of memory and intelligence.

Authors:  F W Sabb; A C Burggren; R G Higier; J Fox; J He; D S Parker; R A Poldrack; W Chu; T D Cannon; N B Freimer; R M Bilder
Journal:  Neuroscience       Date:  2009-05-18       Impact factor: 3.590

Review 6.  Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders.

Authors:  Alvin V Terry; Patrick M Callahan; Caterina M Hernandez
Journal:  Biochem Pharmacol       Date:  2015-07-29       Impact factor: 5.858

7.  Hippocampal and amygdalar local structural differences in elderly patients with schizophrenia.

Authors:  Annapaola Prestia; Enrica Cavedo; Marina Boccardi; Cristina Muscio; Andrea Adorni; Cristina Geroldi; Matteo Bonetti; Paul M Thompson; Giovanni B Frisoni
Journal:  Am J Geriatr Psychiatry       Date:  2014-01-22       Impact factor: 4.105

8.  Hippocampi, thalami, and accumbens microstructural damage in schizophrenia: a volumetry, diffusivity, and neuropsychological study.

Authors:  Ilaria Spoletini; Andrea Cherubini; Giulia Banfi; Ivo Alex Rubino; Patrice Peran; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Schizophr Bull       Date:  2009-06-19       Impact factor: 9.306

Review 9.  A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia.

Authors:  Benjamin K Yee; Philipp Singer
Journal:  Cell Tissue Res       Date:  2013-04-12       Impact factor: 5.249

Review 10.  The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia.

Authors:  Charles B Mikell; Guy M McKhann; Solomon Segal; Robert A McGovern; Matthew B Wallenstein; Holly Moore
Journal:  Stereotact Funct Neurosurg       Date:  2009-06-26       Impact factor: 1.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.